| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $788.1M | — | +25.5% |
| Cost of Revenue | $184.8M | — | +30.6% |
| Gross Profit | $603.4M | — | +24.0% |
| R&D Expense | $200.5M | — | +30.0% |
| SG&A Expense | $65.7M | — | +15.6% |
| Operating Income | -$36.4M | — | -18.6% |
| Pre-tax Income | -$8.4M | — |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.34B | -44.0% | -13.9% |
| Accounts Receivable | $530.5M | -46.5% | +24.9% |
| Current Assets | $4.21B | -14.1% | +23.9% |
| Total Assets | $6.50B | +1.3% | +38.1% |
| Current Liabilities | $2.31B | -5.1% | -22.2% |
| Total Liabilities |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $448.3M | — | +35.3% |
| Capital Expenditures | $17.3M | — | +1.7% |
| Investing Cash Flow | -$1.50B | — | -644.9% |
| Financing Cash Flow | $3.1M | — | +248.7% |
| Free Cash Flow | $431.0M | — | +37.1% |
| -89.7% |
| Income Tax | $3.2M | — | -57.6% |
| Net Income | -$11.6M | — | +3.6% |
| EPS (Basic) | -$0.07 | — | +12.5% |
| EPS (Diluted) | -$0.07 | — | +12.5% |
| $4.52B |
| -2.2% |
| +37.8% |
| Stockholders' Equity | $1.98B | +10.2% | +38.8% |